Education
About Us
Working with TipRanks
Follow Us
Navidea Biopharmaceuticals (NAVB)
OTHER OTC:NAVB
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 65.65K | $ 531.51K | $ 915.01K | $ 26.62K | $ 322.52K |
| Gross Profit | $ -119.30K | $ 332.68K | $ 913.97K | $ 19.95K | $ 225.88K |
| Operating Income | $ -14.05M | $ -12.06M | $ -10.71M | $ -10.96M | $ -10.85M |
| EBITDA | $ -13.88M | $ -11.51M | $ -10.64M | $ -10.82M | $ -10.85M |
| Net Income | $ -15.18M | $ -11.73M | $ -10.64M | $ -10.95M | $ -16.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.00M | $ 4.23M | $ 2.67M | $ 1.05M | $ 4.28M |
| Total Assets | $ 4.37M | $ 6.64M | $ 7.76M | $ 4.15M | $ 7.01M |
| Total Debt | $ 2.44M | $ 749.43K | $ 1.34M | $ 1.07M | $ 316.07K |
| Net Debt | $ 439.76K | $ -3.48M | $ -1.33M | $ 21.69K | $ -3.16M |
| Total Liabilities | $ 12.51M | $ 6.02M | $ 5.71M | $ 5.03M | $ 4.61M |
| Stockholders' Equity | $ -8.44M | $ -106.56K | $ 1.32M | $ -1.61M | $ 1.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.38M | $ -10.55M | $ -8.59M | $ -9.41M | $ 4.23M |
| Operating Cash Flow | $ -8.99M | $ -10.22M | $ -8.17M | $ -9.35M | $ 4.28M |
| Investing Cash Flow | $ -390.35K | $ -329.42K | $ -412.83K | $ 770.42K | $ 953.81K |
| Financing Cash Flow | $ 7.14M | $ 12.11M | $ 10.21M | $ 6.16M | $ -4.55M |